ArticleJournal of cancer research and clinical oncology2025
Comparative effectiveness and safety of enzalutamide versus abiraterone in patients with metastatic castration-resistant prostate cancer: a nationwide registry-based cohort study from Taiwan.
Wen-Kuan Huang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.